Skip to main content

The Genomics ETF on the Front Lines of Cancer Detection

Investors seeking big-time growth potential, thematic exposure, and active management themes may want to give the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) serious consideration. ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.